MBTPS1 and cancer: A variety of agents have been developed to regulate S1P signaling, each with different targets, and clinical development strategies must be tailored to the pathophysiology of the cancer [181,226,227,228,229,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247].